Expressing human papilloma virus oncoproteins. J. Virol. 82, 8820?827 (2008). ten. Ford, C. E., Henry, C., Llamosas, E., Djordjevic, A. Hacker, N. Wnt signalling in gynaecological cancers: a future target for personalised medicine? Gynecol. Oncol. 140, 345?51 (2016). 11. Bahrami, A. et al. Clinical significance and prognosis value of Wnt signaling pathway in cervical cancer. J. Cell. Biochem. 118, 3028?033 (2017). 12. Tomaic, V. Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical websites. Cancers 8, https://doi.org/10.3390/ cancers8100095 (2016). 13. Lichtig, H. et al. HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology 396, 47?eight (2010). 14. Uren, A. et al. Activation in the canonical Wnt pathway through genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res. 65, 6199?206 (2005). 15. Bulut, G. et al. Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice. PLoS 1 six, e27243 (2011). 16. Banister, C. E., Liu, C., Pirisi, L., Creek, K. E. Buckhaults, P. J. Identification and characterization of HPV-independent cervical cancers. Oncotarget eight, 13375?3386 (2017). 17. Ramachandran, I. et al. Wnt inhibitory issue 1 induces apoptosis and inhibits cervical cancer Acupuncture and aromatase Inhibitors Related Products growth, Anaerobe Inhibitors MedChemExpress invasion and angiogenesis in vivo. Oncogene 31, 2725?737 (2012).18. Chang, B. et al. Klotho inhibits the capacity of cell migration and invasion in cervical cancer. Oncol. Rep. 28, 1022?028 (2012). 19. Asem, M. S., Buechler, S., Wates, R. B., Miller, D. L. Stack, M. S. Wnt5a signaling in cancer. Cancers 8, https://doi.org/10.3390/cancers8090079 (2016). 20. Pereira-Suarez, A. L. et al. Frequent alterations in the beta-catenin protein in cancer with the uterine cervix. Tumour Biol. 23, 45?three (2002). 21. Liang, J. et al. Beta-catenin expression negatively correlates with WIF1 and predicts poor clinical outcomes in patients with cervical cancer. Biomed. Res. Int. 2016, 4923903 (2016). 22. Klaus, A. Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer eight, 387?98 (2008). 23. Segditsas, S. Tomlinson, I. Colorectal cancer and genetic alterations inside the Wnt pathway. Oncogene 25, 7531?537 (2006). 24. Poliseno, L. et al. Distinguishing in between nodular and superficial spreading melanoma working with specific microRNA alterations. J. Clin. Oncol. 29, 8540 (2011). 25. Sun, L. et al. NHERF1 regulates actin cytoskeleton organization by way of modulation of alpha-actinin-4 stability. FASEB J. 30, 578?89 (2016). 26. An, H. T., Yoo, S. Ko, J. Alpha-actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis by means of regulation of snail expression and betacatenin stabilization in cervical cancer. Oncogene 35, 5893?904 (2016). 27. Yao, W. et al. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation. Amino Acids 43, 2027?035 (2012). 28. Cardone, R. A. et al. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38mediated NHE1 activation and invasion in breast tumor cells. Mol. Biol. Cell 18, 1768?780 (2007). 29. Malfettone, A., Saponaro, C., Paradiso, A., Simone, G. Mangia, A. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer connected with poor prognosis. BMC Cancer 12, 106 (2012). 30. Tabrizi, A. D. et al. Major ovarian mucinous carcinoma of intestinal sort: significance of pattern of invasion and immunohistochemical expressio.